Latest News, Announcements, and Press Releases

REDWOOD CITY, Calif., Oct 02, 2013 (BUSINESS WIRE) –Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that it has been named as a finalist for the CPhI Pharma Awards…

— Conference call on August 15th at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 9, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that the company has received notice from Dyadic International, Inc. alleging that Codexis is in…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Aug. 5, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that the company has rescheduled the release of its second quarter financial results due to…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Jul. 24, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced it will host a live conference call and audio webcast on Wednesday, August 7, 2013…

BALA CYNWYD, Pa. & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Jul. 15, 2013– Purolite Corporation and Codexis, Inc. (NASDAQ:CDXS) today announced a joint collaboration to develop and market immobilized enzymes for the pharmaceutical industry. Enzymes are immobilized through binding to inert…

REDWOOD CITY, Calif. & TORTONA, Italy–(BUSINESS WIRE)–Jun. 14, 2013– Codexis (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, and Chemtex, a leader in chemical engineering and renewable processes, today announced the successful scale-up…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Jun. 4, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced the appointment of Scott Watson as Vice President of Sales and Marketing, effective May 2013.…

REDWOOD CITY, Calif.–(BUSINESS WIRE)–May. 14, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the…

— Product gross margin increases to 38%; Product revenue up 34% from fourth quarter 2012 — — Conference call today at 4:30 pm ET — REDWOOD CITY, Calif.–(BUSINESS WIRE)–May. 7, 2013– Codexis, Inc. (NASDAQ: CDXS), a developer of…